Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00709787
Previous Study | Return to List | Next Study

Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00709787
Recruitment Status : Completed
First Posted : July 3, 2008
Last Update Posted : March 10, 2017
Sponsor:
Information provided by (Responsible Party):
Pfizer

Tracking Information
First Submitted Date July 1, 2008
First Posted Date July 3, 2008
Last Update Posted Date March 10, 2017
Study Start Date June 2008
Actual Primary Completion Date February 2009   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: November 26, 2008)
Description of hypertensive patients in terms of presence of associated cardiovascular (CV) risk factors (number of additional CV risk factors and frequency)
Original Primary Outcome Measures
 (submitted: July 1, 2008)
Description of hypertensive patients in terms of presence of associated cardiovascular (CV) risk factors (number of additional CV risk factors and frequency) [ Time Frame: Time Frame is N/A ]
Change History Complete list of historical versions of study NCT00709787 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures
 (submitted: November 26, 2008)
  • Description of pattern of management of HT and CVD prevention, through lifestyle and use of drug therapies,
  • Estimate adherence to treatment using the Morisky Adherence Scale (MAS)
  • Estimation of hypertensive patients CV risk stratification based on ESH/ESC Hypertension Guidelines 2007 and to compare it with physicians' estimation of CV risk.
Original Secondary Outcome Measures
 (submitted: July 1, 2008)
  • Description of pattern of management of HT and CVD prevention, through lifestyle and use of drug therapies, [ Time Frame: Time Frame is N/A ]
  • Estimate adherence to treatment using the Morisky Adherence Scale (MAS) [ Time Frame: Time Frame is N/A ]
  • Estimation of hypertensive patients CV risk stratification based on ESH/ESC Hypertension Guidelines 2007 and to compare it with physicians' estimation of CV risk. [ Time Frame: Time Frame is N/A ]
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management
Official Title Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management
Brief Summary To assess the pattern of hypertension in the population in terms of presence of additional risk factors (ARF) and cardiovascular risk stratification.
Detailed Description routine physician visits
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Adult Hypertensive Patients managed in primary care
Condition Hypertension
Intervention Other: Usual Care
Normal care for hypertensive patients with risk factors for CHD
Study Groups/Cohorts Hypertensive Subjects undergoing primary prevention
Intervention: Other: Usual Care
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: March 10, 2009)
899
Original Estimated Enrollment
 (submitted: July 1, 2008)
4050
Actual Study Completion Date February 2009
Actual Primary Completion Date February 2009   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Age 18 to 80 years old
  • Patients with hypertension: newly diagnosed and /or already diagnosed and treated , whether at goal or not for the blood pressure level;
  • Patients with no history of CHD/CVD

Exclusion Criteria:

  • None
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 80 Years   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Croatia,   Czech Republic
Removed Location Countries  
 
Administrative Information
NCT Number NCT00709787
Other Study ID Numbers A3841059
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Pfizer
Study Sponsor Pfizer
Collaborators Not Provided
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
PRS Account Pfizer
Verification Date March 2017